Your browser doesn't support javascript.
loading
Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC.
Hellmann, Matthew D; Nabet, Barzin Y; Rizvi, Hira; Chaudhuri, Aadel A; Wells, Daniel K; Dunphy, Mark P S; Chabon, Jacob J; Liu, Chih Long; Hui, Angela B; Arbour, Kathryn C; Luo, Jia; Preeshagul, Isabel R; Moding, Everett J; Almanza, Diego; Bonilla, Rene F; Sauter, Jennifer L; Choi, Hyejin; Tenet, Megan; Abu-Akeel, Mohsen; Plodkowski, Andrew J; Perez Johnston, Rocio; Yoo, Christopher H; Ko, Ryan B; Stehr, Henning; Gojenola, Linda; Wakelee, Heather A; Padda, Sukhmani K; Neal, Joel W; Chaft, Jamie E; Kris, Mark G; Rudin, Charles M; Merghoub, Taha; Li, Bob T; Alizadeh, Ash A; Diehn, Maximilian.
Afiliación
  • Hellmann MD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. diehn@stanford.edu arasha@stanford.edu hellmanm@mskcc.org.
  • Nabet BY; Weill Cornell School of Medicine, New York, New York.
  • Rizvi H; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chaudhuri AA; Parker Center for Cancer Immunotherapy, San Francisco, California.
  • Wells DK; Department of Radiation Oncology, Stanford University, Stanford, California.
  • Dunphy MPS; Stanford Cancer Institute, Stanford University, Stanford, California.
  • Chabon JJ; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Liu CL; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Hui AB; Parker Center for Cancer Immunotherapy, San Francisco, California.
  • Arbour KC; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Luo J; Department of Radiation Oncology, Stanford University, Stanford, California.
  • Preeshagul IR; Stanford Cancer Institute, Stanford University, Stanford, California.
  • Moding EJ; Stanford Cancer Institute, Stanford University, Stanford, California.
  • Almanza D; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, California.
  • Bonilla RF; Department of Radiation Oncology, Stanford University, Stanford, California.
  • Sauter JL; Stanford Cancer Institute, Stanford University, Stanford, California.
  • Choi H; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Tenet M; Weill Cornell School of Medicine, New York, New York.
  • Abu-Akeel M; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Plodkowski AJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Perez Johnston R; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Yoo CH; Department of Radiation Oncology, Stanford University, Stanford, California.
  • Ko RB; Stanford Cancer Institute, Stanford University, Stanford, California.
  • Stehr H; Department of Radiation Oncology, Stanford University, Stanford, California.
  • Gojenola L; Stanford Cancer Institute, Stanford University, Stanford, California.
  • Wakelee HA; Department of Radiation Oncology, Stanford University, Stanford, California.
  • Padda SK; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Neal JW; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chaft JE; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Kris MG; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Rudin CM; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Merghoub T; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Li BT; Department of Radiation Oncology, Stanford University, Stanford, California.
  • Alizadeh AA; Department of Radiation Oncology, Stanford University, Stanford, California.
  • Diehn M; Department of Pathology, Stanford University, Stanford, California.
Clin Cancer Res ; 26(12): 2849-2858, 2020 06 15.
Article en En | MEDLINE | ID: mdl-32046999
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Carcinoma de Pulmón de Células no Pequeñas / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Antígeno B7-H1 / ADN Tumoral Circulante / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Carcinoma de Pulmón de Células no Pequeñas / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Antígeno B7-H1 / ADN Tumoral Circulante / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article